|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Dar Al Dawa Development & Investment Co. (دار الدواء للتنمية)
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Dar Al Dawa Development & Investment Co. (دار الدواء للتنمية) Headquarters P.O. Box 9364, Al Noor Building, Wadi Saqrah Street, Amman 11191.; Amman; Amman |
Status: Listed Legal Form: Other non-liability limited Operational Status: Operational ISIN CODE : JO4101211012 Financial Auditors: Ernst & Young (2012) Total Employees: 849 Tel: 962 65539176 |
|
Company Description |
| Dar Al Dawa Development and Investment Company (Dar Al Dawa) is a Jordan-based public shareholding company that is engaged in the manufacture and marketing of chemical, medical and pharmaceutical products and its accessories. The Company produces a range of pharmaceutical products including Antibiotics, Antihyperglycemics, Chemotherapeutics, Cardiovascular products, Dermatological products, Ophthalmology products, Respiratory products, Mouth Washes, Vitamin Preparations and many others. Dar Al Dawa | ||
|
||
Company Analysis |
| According to the Individual - Audited financial statement for the Year of 2010, total net operating revenues increased with 3.54%, from JOD 44,650.838 thousands to JOD 46,229.986 thousands. The results of the period increased 50.32% reaching JOD 9,111.137 thousands at the end of the period against JOD 6,061.078 thousands last year. Return on equity (Net income/Total equity) went from 11.13% to 15.27%, the Return On Asset (Net income / Total Asset) went from 6.79% to 8.88% and the Net Profit Margin (Net Income/Net Sales) went from 13.57% to 19.71% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 71.99% compared to 63.85% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.94 to 3.85 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2011 Y (non-cons) |
2010 Y (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| Finglobe - MENA Spread Financial Statements | Finglobe - MENA Spread Financial Statements | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
90,284 |
102,625 |
| ||
Current Assets |
25,023 |
30,430 |
| ||
Total Liabilities |
36,848 |
42,956 |
| ||
Shareholders Equity |
53,436 |
59,668 |
| ||
Current Liabilities |
4,435 |
7,908 |
| ||
| * All the accounts are in JOD. | ||
Income Statement
| ||
Total Operating Revenue |
41,054 |
46,229 |
| ||
Net Profit (Loss) |
-5,867 |
9,111 |
| ||
| * All the accounts are in JOD. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
-6.5% |
8.88% |
| ||
Annualised Return on Assets (ROA) |
-6.5% |
8.88% |
| ||
Return on Equity (ROE) |
-10.98% |
15.27% |
| ||
Annualised Return on Equity (ROE) |
-9.83% |
16.73% |
| ||
Return on Sales (ROS) |
-14.29% |
19.71% |
| ||
Gross Profit Margin |
158.13% |
153.74% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
1.89x |
1.29x |
| ||
Inventory Turnover |
2.45x |
2.14x |
| ||
Current asset turnover |
1.64x |
1.52x |
| ||
Fixed-asset turnover |
0.63x |
0.64x |
| ||
Asset Turnover |
0.45x |
0.45x |
| Valuation figures and ratios | ||
| ||
Enterprise value |
65,271 |
97,997 |
| ||
Bookvalue (BV) |
53,436 |
59,668 |
| ||
Net Cash |
-18,271 |
-21,997 |
| Liquidity Ratios | ||
| ||
Current Ratio |
564.18% |
384.81% |
| ||
Quick ratio |
185.74% |
112.09% |
| ||
Doom's day ratio |
418.81% |
265.03% |
| Leverage Ratios | ||
| ||
Leverage ratio |
168.96% |
171.99% |
| ||
Debt to equity |
68.96% |
71.99% |
| ||
Debt to total assets |
40.81% |
41.86% |
| ||
Long Term Debt to Capital |
37.76% |
37% |
| Market ratios | ||
| ||
Market Cap / Net cash |
-2.57 |
-3.45 |
| Trend Ratios | ||
| ||
Revenue Trend |
88.81% |
103.54% |
| ||
Net Income Trend |
-64.4% |
150.32% |
| ||
 |